OrbusNeich Medical Group Holdings (FRA:Q8T) Total Operating Expense: €71.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:Q8T OrbusNeich Medical Group Holdings Ltd FRA:Q8T
96 GF Score
Price €0.35
GF Value €0.49
! 2 Warning Signs
View Full Analysis

What is OrbusNeich Medical Group Holdings Total Operating Expense?

OrbusNeich Medical Group Holdings FRA:Q8T 96 Total Operating Expense is €71.0 Mil as of Dec. 2025. GuruFocus rates FRA:Q8T with a GF Score™ of 96/100 and a GF Value™ of €0.49. The stock has 2 warning signs investors should review.

OrbusNeich Medical Group Holdings's Total Operating Expense for the six months ended in Dec. 2025 was €36.6 Mil. OrbusNeich Medical Group Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €71.0 Mil.

OrbusNeich Medical Group Holdings Total Operating Expense Related Terms

OrbusNeich Medical Group Holdings Total Operating Expense Historical Data

* Premium members only.

The historical data trend for OrbusNeich Medical Group Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings Total Operating Expense Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 53.83 64.50 61.53 75.74 70.44

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.07 35.90 38.84 34.35 36.61
FRA:Q8T
96GF Score
OrbusNeich Medical Group Holdings Ltd FRA:Q8T
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrbusNeich Medical Group Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €71.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €71.0 Mil mean?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a Total Operating Expense of €71.0 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on OrbusNeich Medical Group Holdings and its competitors.
Is OrbusNeich Medical Group Holdings' Total Operating Expense too high?
OrbusNeich Medical Group Holdings' current Total Operating Expense is €71.0 Mil. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' Total Operating Expense compare to ISRG and BDX?
OrbusNeich Medical Group Holdings' Total Operating Expense of €71.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on OrbusNeich Medical Group Holdings and its competitors. OrbusNeich Medical Group Holdings's current Total Operating Expense is €71.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current Total Operating Expense of €71.0 Mil. The stock's GF Value™ is €0.49, compared to a current price of €0.35 — trading 28.6% below its estimated fair value. The current Total Operating Expense is €71.0 Mil. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current Total Operating Expense is €71.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?

Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued. The current stock price of €0.35 is trading 28.6% below its estimated GF Value™ of €0.49.

Key valuation signals for FRA:Q8T:

  • Total Operating Expense: €71.0 Mil
  • GF Value™: €0.49 vs. price of €0.35 (28.6% below fair value)
  • GF Score™: 96/100 with 2 warning signs

No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OrbusNeich Medical Group Holdings Business Description

Other Exchanges 06929:Hong Kong
Address 3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score

Get the complete analysis for FRA:Q8T

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.35
Price
€0.49
GF Value